Published: 2020-09-23

An unusual case of primary peritoneal adenocarcinoma

Rajdave Singh Sadu Singh, Muhammad Rahimi Mohamad Hisham, Ahmad Tarmizi Mohammad, Shabbar Husain Fazle Abbas, Yussra Yusoff


Primary peritoneal adenocarcinoma is sporadic with few cases cited in pre-existing literature. This cancer arises from the peritoneal epithelium lining of the abdomen, which is derived from extra ovarian mesothelium. It generally carries a poor prognosis. The treatment strategies are similar to ovarian serous papillary carcinoma. Report an incidental finding of primary peritoneal adenocarcinoma in a 39-year-old female army personnel, currently undergoing her chemotherapy and thriving. Exploratory laparotomy was done given the incidental finding of a mass on the contrast-enhanced computed tomography scan (CT). The mass was attached to the greater omentum, however, did not invade the mucosa of the transverse colon. Given this, part of greater omentum was removed. The findings of the immunohistochemical studies of the tumour are described within this report. The diagnosis of a primary peritoneal adenocarcinoma, stage II was established as no other primary site were found upon further investigation. The patient was treated with chemotherapy (carboplatin/paclitaxel) which was planned for 6 cycles. Otherwise, the patient had an uneventful postoperative course, is underway her chemotherapy regime and is planned for interim CT study to assess chemotherapy response. To conclude, isolated solitary primary peritoneal adenocarcinoma without peritoneal carcinomatosis, gastrointestinal manifestations and ascites are rare. This case, however, demonstrates the importance of its diagnosis, accurate evaluation and management.


Peritoneal carcinoma, Adenocarcinoma, Omental tumor

Full Text:



Jordan SJ, Green AC, Whiteman DC, Moore SP, Bain CJ, Gertig DM et al. Serous ovarian, fallopian tube and primary peritoneal cancers: A comparative epidemiological analysis. Int J Cancer. 2008;122(7):1598-603.

Goodman MT, Shvetsov YB. Incidence of ovarian, peritoneal, and fallopian tube carcinomas in the United States, 1995-2004. Cancer Epidemiol Biomarkers Prev. 2009;18(1):132-9.

Nicolas G, Kfoury T, Fawaz H, Issa M. Extraovarian primary peritoneal carcinomatosis: A case report. Am J Case Rep. 2017;18:714-8.

Zeppernick F, Meinhold-Heerlein I. The new FIGO staging system for ovarian, fallopian tube, and primary peritoneal cancer. Arch Gynecol Obstet. 2014;290(5):839–42.

Gooneratne S, Sassone M, Blaustein A, Talerman A.Serous surface papillary carcinoma of the ovary: a clinicopathologic study of 16 cases. Int J Gynecol Pathol. 1982;1(3):258-69.

Altaras MM, Aviram R, Cohen I, Cordoba M, Weiss E, Beyth Y. Primary peritoneal papillary serous adenocarcinoma: Clinical and management aspects. Gynecol Oncol. 1990;40(3):230-6.

Truong LD, Maccato ML, Awalt H, Cagle PT, Schwartz MR, Kaplan AL. Serous surface carcinoma of the peritoneum: A clinicopathologic study of 22 cases. Hum Pathol. 1990;21(1):99-110.

Alok AK, O’Reilly AP. Extraovarian peritoneal serous papillary carcinoma: Case report. Eur J Gynaecol Oncol. 1998;19(4):347-9.

Lele SB, Piver MS, Matharu J, Tsukada Y. Peritoneal papillary carcinoma. Gynecol Oncol. 1988;31(2):315-20.

Swerdlow M. Mesothelioma of the pelvic peritoneum resembling papillary cystadenocarcinoma of the ovary. Case report. Am J Obstet Gynecol. 1959;77(1):197-200.

Shmueli E, Leider-Trejo L, Schwartz I, Aderka D, Inbar M. Primary papillary serous carcinoma of the peritoneum in a man. Ann Oncol. 2001;12(4):563-7.

Ayhan A, Taskiran C, Yigit-Celik N, Bozdag G, Gultekin M, Usubutun A et al. Long-term survival after paclitaxel plus platinum-based combination chemotherapy for extraovarian peritoneal serous papillary carcinoma: is it different from that for ovarian serous papillary cancer? Int J Gynecol Cancer. 2006;16(2):484-9.

Ransom DT, Shreyaskumar R, Patel M, Gary L, Keeney George D, Malkasian M et al. Edmonson M. Clinical Trials. 1989;33(3):1-2.